Aclaris Therapeutics, Inc.
ACRS
$3.59
$0.298.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 90.75M | 95.91M | 99.81M | 105.31M | 113.59M |
| Total Receivables | 5.57M | 4.68M | 194.00K | 250.00K | 12.36M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 4.20M | 3.23M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 96.32M | 100.59M | 104.20M | 108.79M | 125.95M |
|
|
|||||
| Total Current Assets | 96.32M | 100.59M | 104.20M | 108.79M | 125.95M |
| Net Property, Plant & Equipment | 3.05M | 3.24M | 3.44M | 3.65M | 3.85M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 486.00K | 406.00K | 424.00K | 444.00K | 224.00K |
| Total Assets | 160.46M | 175.53M | 189.15M | 198.09M | 220.33M |
|
|
|||||
| Total Accounts Payable | 13.16M | 9.19M | 8.80M | 6.35M | 4.69M |
| Total Accrued Expenses | 7.41M | 5.83M | 4.85M | 4.58M | 7.76M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 551.00K | 533.00K | 515.00K | 498.00K | 481.00K |
| Total Finance Division Other Current Liabilities | 7.52M | 10.08M | 12.68M | 10.08M | 18.66M |
| Total Other Current Liabilities | 7.52M | 10.08M | 12.68M | 10.08M | 18.66M |
| Total Current Liabilities | 28.65M | 25.63M | 26.84M | 21.51M | 31.60M |
|
|
|||||
| Total Current Liabilities | 28.65M | 25.63M | 26.84M | 21.51M | 31.60M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.57M | 1.71M | 1.85M | 1.99M | 2.12M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 27.17M | 28.09M | 28.72M | 30.53M | 31.06M |
| Total Liabilities | 57.38M | 55.43M | 57.41M | 54.03M | 64.77M |
|
|
|||||
| Common Stock & APIC | 1.07B | 1.07B | 1.06B | 1.06B | 1.06B |
| Retained Earnings | -967.78M | -947.99M | -933.38M | -917.95M | -902.86M |
| Treasury Stock & Other | 610.00K | 597.00K | 482.00K | 434.00K | 97.00K |
| Total Common Equity | 103.08M | 120.10M | 131.74M | 144.07M | 155.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 103.08M | 120.10M | 131.74M | 144.07M | 155.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 103.08M | 120.10M | 131.74M | 144.07M | 155.55M |
|
|
|||||